NEW ORLEANS – May 9, 2019 /Canna Newswire/ – Navigator Genomics™ (NGT) has signed three new affiliate agreements to collaborate with Dr. Michele Ross, CEO of Infused Health, Dr. Lakisha Jenkins (Jamaica), and Donna Shields, MS, RDN to provide NGT’s educational content services for their clients.
Navigator’s affiliates receive news articles, links to NGT’s fully vetted cannabis glossaries, videos, webinars, science whitepapers, and chronic medical condition information focused on the very same conditions people must have to qualify for medical cannabis, all content is no cost to affiliates.
Dr. Michele Ross, CEO of Infused Health, is a neuroscientist who first published on the endocannabinoid system in 2006 and went from academia to cannabis health coaching after cannabis helped her recover from several chronic health issues including fibromyalgia. Infused Health is an online cannabis coaching network supporting clients who need more information about cannabis treatment than their doctors or budtenders can provide. She focuses on helping women & adult patients with chronic pain, anxiety, and depression live healthier & happier lives by using the right cannabis products.
“Navigator Genomics is the perfect tool for determining whether or not it is safe for a patient to take cannabis products containing THC or CBD with their current medications,” said Dr. Ross. “Most of our Infused Health clients are on more than one medication, and this genetic test helps prevent dangerous drug-drug interactions.”
Dr. Lakisha Jenkins-(Jamaica) is a Cannabis Practitioner, Naturopath, Registered Master Herbalist and teacher of the endogenous cannabinoid system.
Dr. Jenkins involvement in medical cannabis began in 2006. She was a Founding Board Member & first elected President of the California Cannabis Industry Association in 2012 , the National Cannabis Industry Association Board (2013-2015) & the founding Chair of their Minority Business Council. Dr Jenkins works to ensure all people have the right to choose their best treatment options.
Donna Shields, MS, RDN is co-founder of the Holistic Cannabis Academy, an online education training program using an integrative medicine approach. Her diverse career spans the US Army Medical Corp, global health communications for The Coca-Cola Company & faculty at the Culinary Institute of America. Based in Colorado and Florida, she’s been a contributor to The Cannabis Kitchen Cookbook and consults for the cannabis and hemp industries. https://donnashields.net/
About Navigator Genomics™
NGT is the first pharmacogenomics company to measure & report your personal genetic responses to key cannabinoids utilized in Medical Cannabis (MMJ), simultaneously with 416 of the most popularly prescribed prescription medications (Rx) taken by the most amount of people. Results include important potential drug-drug interactions which can reduce or cancel efficacy of MMJ or Rx’s, create unwanted side-effects or even adverse reactions. Consumers can avoid costs & time of traditional “trial and error” dosing. Results help personalize which cannabinoids & medications can work best for each person. NGT’s lab is CLIA & CAP accredited to ensure highest quality standards. All information is private and HIPAA compliant. Tests are $299 sold direct-to-consumer on line at: https://navigatorgenomics.com
*Navigator is actively seeking affiliates to collaborate with medical cannabis digital publications, educators, cannabis doctor organizations, researchers, MMJ science studies, product manufacturers, dispensaries, and analytic data firms. Navigator provides free educational content, videos, webinars, news articles, etc. to affiliates who desire to educate their constituents.
# CNW #
Navigator Genomics Testing